-
Garden Reach Sh.
2,898.40 2,834.60(%) -
Reliance Power
53.00 54.25(%) -
Cochin Shipyard
1,955.00 2,977.10(%) -
Max Financial
1,474.10 1,425.00(%) -
Waaree Energies
2,666.00 1,808.65(%) -
Mazagon Dock
3,562.00 3,737.05(%) -
The Ramco Cement
1,009.50 1,059.80(%) -
Tata Tele. Mah.
73.30 50.01(%) -
IFCI
56.25 91.39(%) -
Eternal Ltd
240.70 304.50(%) -
Bajaj Finserv
2,048.45 2,134.45(%) -
Macrotech Devel.
1,425.50 1,648.00(%) -
Kajaria Ceramics
1,004.85 1,578.25(%) -
Bharat Electron
389.90 386.70(%) -
ITC
439.00 500.01(%) -
Angel One
3,100.25 3,502.60(%) -
Reliance Industr
1,433.70 1,608.95(%) -
HDFC Bank
1,936.95 1,977.95(%) -
Infosys
1,586.50 2,006.80(%) -
DLF
770.40 601.20(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Biofil Chemicals & Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations
- Systematix
- BSE Code : 3284.0
- ISIN : INE829A01014
-
Today’s Low
45.00 -
Today’s High
46.88

-
Open
46.88 -
Perv Close
46.38 -
52W Low
40.40 -
52W High
91.87
Key Indicators
-
P/E(TTM)
123.08
-
Mar.Cap (₹Cr.)
73.87
-
Div & Yield %
0.00
-
Book Value(₹)
11.30
-
Debt-Equity Ratio
-2.11
-
AGM Date
22-May-2025
-
EPS
0.37
-
P/E Ratio
123.08
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
73.87
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
16.27
-
BV (₹)
11.30
-
Sales( ₹ in Cr.)
40.04
-
NP (in Cr.)
0.71
-
NP Var(%)
27.0
-
Div%
0.0
-
CPS (₹)
0.70
-
EPS (₹)
0.40
-
Traded Value (₹ in Lakhs)
74.09
-
52 Week High
91.87
-
52 Week Low
40.40
-
Price BSE
46.0
-
Price NSE
45.00
-
Market Capital( in Cr.)
74.09
-
P/C Ratio
67.50
-
P/E Ratio
105.50
-
Price Vs.BV
0.40
-
12-Feb-2025( 07:33)
Results - Announcements - Biofi... - Net profit of Biofil Chemicals...
-
05-Feb-2025( 12:49)
Corporate News - Biofi... - Biofil Chemicals & Pharmaceuti...
-
15-Nov-2024( 09:55)
Results - Announcements - Biofi... - Net profit of Biofil Chemicals...
-
08-Nov-2024( 04:59)
Corporate News - Biofi... - Biofil Chemicals & Pharmaceuti...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 40.04 | 30.04 | 22.38 | 35.75 | 29.69 | 23.13 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 40.04 | 30.04 | 22.38 | 35.75 | 29.69 | 23.13 |
Other Income | 0.49 | 0.10 | 0.15 | 0.80 | 0.17 | 0.10 |
Stock Adjustments | 0.27 | 0.20 | -3.59 | 2.77 | 0.34 | -0.17 |
Total Income | 40.80 | 30.34 | 18.94 | 39.32 | 30.20 | 23.06 |
EXPENDITURE : | ||||||
Raw Materials | 37.78 | 27.62 | 15.87 | 35.20 | 25.65 | 19.82 |
Power and Fuel Cost | 0.38 | 0.33 | 0.30 | 0.29 | 0.49 | 0.37 |
Employee Cost | 0.50 | 0.45 | 0.79 | 0.75 | 0.86 | 0.89 |
Other Manufacturing Expenses | 0.17 | 0.05 | 0.09 | 0.23 | 0.40 | 0.11 |
Selling and Administration Expenses | 0.56 | 0.54 | 0.37 | 0.37 | 0.78 | 0.72 |
Miscellaneous Expenses | 0.11 | 0.08 | 0.05 | 0.08 | 0.03 | 0.02 |
Employee Benefit Expenses | 0.50 | 0.45 | 0.79 | 0.75 | 0.86 | 0.89 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 39.49 | 29.06 | 17.46 | 36.92 | 28.21 | 21.93 |
Operating Profit | 1.30 | 1.26 | 1.48 | 2.40 | 1.99 | 1.12 |
Interest | 0.04 | 0.04 | 0.04 | 0.07 | 0.12 | 0.16 |
Gross Profit | 1.26 | 1.22 | 1.44 | 2.33 | 1.87 | 0.96 |
Depreciation | 0.40 | 0.43 | 0.43 | 0.41 | 0.41 | 0.37 |
Profit Before Tax | 0.86 | 0.79 | 1.01 | 1.92 | 1.46 | 0.59 |
Current Tax | 0.24 | 0.22 | 0.28 | 0.32 | 0.26 | 0.12 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -0.09 | 0.01 | 0.04 | 0.35 | 0.00 | 0.00 |
Reported Net Profit | 0.71 | 0.56 | 0.70 | 1.24 | 1.21 | 0.48 |
Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Net Profit | 0.71 | 0.56 | 0.70 | 1.24 | 1.21 | 0.48 |
Adjustment below Net Profit | 0.19 | -0.10 | 0.04 | 0.00 | 0.03 | 0.00 |
P & L Balance brought forward | -32.60 | -33.06 | -33.79 | -35.01 | -36.25 | -36.73 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance carried down | -31.69 | -32.60 | -33.06 | -33.77 | -35.01 | -36.25 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | 0.44 | 0.34 | 0.43 | 0.76 | 0.74 | 0.30 |
Earnings Per Share(Adj)-Unit Curr | 0.44 | 0.34 | 0.43 | 0.76 | 0.74 | 0.30 |
Book Value | 11.19 | 10.63 | 10.35 | 9.91 | 9.15 | 8.39 |
Book Value(Adj)-Unit Curr | 11.19 | 10.63 | 10.35 | 9.91 | 9.15 | 8.39 |